LCAM
OMGA

Long Corridor Asset Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Long Corridor Asset Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-85,000
Closed -$63.4K – 28
2024
Q4 		$63.4K Hold
85,000
– – 0.05% 20
2024
Q3 		$104K Hold
85,000
– – 0.09% 20
2024
Q2 		$176K Buy
+85,000
New +$200K 0.17% 19

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Long Corridor Asset Management's OMGA Position: Q1 2025 in Review

Long Corridor Asset Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 85,000 shares — an estimated $63.4K sold.

Long Corridor Asset Management first reported a position in OMGA in Q2 2024 and held it in 3 quarters. The position peaked at $176K in Q2 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Long Corridor Asset Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Long Corridor Asset Management sold 85,000 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $63.4K.
  • Long Corridor Asset Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2024 and held it in 3 quarters.
  • Long Corridor Asset Management's Omega Therapeutics, Inc. Common Stock position peaked at $176K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Long Corridor Asset Management's 13F filing for Q1 2025, filed 13 May 2025.